VistaGen Therapeutics (VTGN)

• Market cap: $194M
• 1 day: 7.93%
• 5 days: 9.62%
• 1 month: 20.99%
• 3 months: 51.7%
• 6 months: 93.68%
• Year to date: 47.59%
• 1 year: 72.54%
• 5 years: -78.58%
• 10 years: -96.03%
• Sector: Healthcare
• Industry: Biotechnology

About: Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Employees: 59